An interventional study of Propranolol and Diltiazem in Oral Diltiazim, Oral Propranolol and Hypotension, sponsored by Assiut University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Assiut University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Hypotension by Assiut University — 6 open to participants now, 6 under way, 1 of them phase 3. Hypotension · Assiut University.
Among the 16 studies in Hypotension by Assiut University, this one is the 10th largest by enrollment, is one of 2 that started in 2024, is one of 7 with no phase, and was the 16th registered.
889 studies on the registry are indexed under Hypotension; 197 are open to participants now.
Browse Hypotension studies →6 of the 16 studies in Hypotension by Assiut University are open now, in 1 country. Recruiting first, the newest first:
Assiut University · Sites in Egypt
Ages 18–70
Assiut University · Sites in Egypt
Ages 19–40 · Women only
Assiut University · Sites in Egypt
Ages 65+
Assiut University
Ages 18–65
Assiut University
Ages 18–70
By country, each count listing its studies:
Of the 112 Hypotension studies recruiting now, 51 (46%) set no upper age limit and 36 (32%) stop at 75 or younger; 7 take children under 18; 15 take healthy volunteers.
This study: 18 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 4 · Phase 3 2 · Phase 4 2
First in 2016; this study’s year is marked. 2 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 80 is close to the median of 86 across 592 interventional studies indexed under Hypotension.
Median enrollment 95 across the 16 interventional studies. Of the 6 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Assiut University is the lead sponsor of 5,092 studies on the registry; 2,187 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
3 of the studies in Hypotension by Assiut University that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06727201Phase 3Assiut UniversityRole of Ondansetron in Spinal Anaesthesia Induced Hypotension | 2026-12-01 |
| NCT06753409Assiut UniversityProcessed Electroencephalography-guided General Anesthesia and Outcomes in Major Abdominal Surgery | 2026-12-01 |
| NCT07869693Assiut UniversityPre-induction Norepinephrine in Septic Patients Undergoing Surgery | 2027-10-10 |
Add all 3 to your calendar (.ics) → With an account.
Among the 16 studies in Hypotension by Assiut University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to compare the efficacy of preoperative oral diltiazem and oral propranolol in achieving controlled hypotension during functional endoscopic sinus surgery (FESS).
Functional endoscopic sinus surgery (FESS) is the standard minimally invasive surgical approach for the management of chronic rhinosinusitis and other sinonasal diseases refractory to medical treatment.
Propranolol is a non-selective β-adrenergic receptor antagonist that decreases heart rate, myocardial contractility, and cardiac output, thereby reducing arterial blood pressure and attenuating the sympathetic response to laryngoscopy and surgical stimulation.
Diltiazem is a non-dihydropyridine calcium channel blocker that inhibits calcium influx into cardiac myocytes and vascular smooth muscle cells, resulting in arterial vasodilation together with negative chronotropic and mild negative inotropic effects.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients will receive one tablet (10 mg) of oral propranolol hydrochloride (Inderal) at 8:00 pm the night before surgery, and another one tablet (10 mg) with a small sip of water one hour before induction of anesthesia.
Drug: Propranolol
Patients will receive one tablet of oral diltiazem (60 mg) at 8:00 PM on the night before surgery and another (60 mg) tablet with a small sip of water 1 hour before induction of anesthesia.
Drug: Diltiazem
Patients will receive one tablet (10 mg) of oral propranolol hydrochloride (Inderal) at 8:00 pm the night before surgery, and another one tablet (10 mg) with a small sip of water one hour before induction of anesthesia.
Patients will receive one tablet of oral diltiazem (60 mg) at 8:00 PM on the night before surgery and another (60 mg) tablet with a small sip of water 1 hour before induction of anesthesia.
Incidence of hypotension
Incidence of hypotension will be recorded.
Time frame: 24 hours postoperatively
Quality of the surgical field
The quality of the surgical field will be evaluated using the Fromme-Boezaart Surgical Field Grading Scale, while surgeon satisfaction will be assessed using a 5-point Likert scale (1 = very poor, 2 = poor, 3 = fair, 4 = good, and 5 = excellent)
Time frame: 24 hours postoperatively
Heart rate
Heart rate will be recorded at baseline (before administration of the study medication), before induction of anesthesia, after induction, immediately after endotracheal intubation, every 5 minutes throughout surgery, and at the end of the procedure.
Time frame: Till the end of surgery (Up to 2 hours)
Systolic blood pressure
Systolic blood pressure will be recorded at baseline (before administration of the study medication), before induction of anesthesia, after induction, immediately after endotracheal intubation, every 5 minutes throughout surgery, and at the end of the procedure.
Time frame: Till the end of surgery (Up to 2 hours)
Diastolic blood pressure
Diastolic blood pressure will be recorded at baseline (before administration of the study medication), before induction of anesthesia, after induction, immediately after endotracheal intubation, every 5 minutes throughout surgery, and at the end of the procedure.
Time frame: Till the end of surgery (Up to 2 hours)
Mean arterial pressure
Mean arterial pressure will be recorded at baseline (before administration of the study medication), before induction of anesthesia, after induction, immediately after endotracheal intubation, every 5 minutes throughout surgery, and at the end of the procedure.
Time frame: Till the end of surgery (Up to 2 hours)
Total intraoperative blood loss
Total intraoperative blood loss will be estimated by measuring the volume of blood collected in the graduated suction canister after subtraction of the irrigation fluid used during surgery.
Time frame: Intraoperatively
Time to extubation
Time to extubation (minutes), measured from discontinuation of anesthetic agents until successful tracheal extubation.
Time frame: Until successful tracheal extubation (Up to 2 hours)
Total intraoperative nitroglycerin consumption
Total intraoperative nitroglycerin consumption will be recorded.
Time frame: Intraoperatively
Time to discharge from the post-anesthesia care unit
Time to discharge from the post-anesthesia care unit (PACU) will be recorded according to standard discharge criteria.
Time frame: Till the discharge from the post-anesthesia care unit (Up to 2 weeks)
Degree of surgeon satisfaction
Surgeon satisfaction will be assessed using a 5-point Likert scale (1 = very poor, 2 = poor, 3 = fair, 4 = good, and 5 = excellent).
Time frame: 24 hours postoperatively
Incidence of adverse events
Incidence of adverse events such as bradycardia, arrhythmias, bronchospasm, nausea, vomiting, excessive bleeding, or any other drug-related complications.
Time frame: 24 hours postoperatively
Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.
Supporting information: Study protocol
Time frame: After the end of study for one year.
Access criteria: The data will be available upon a reasonable request from the corresponding author.
No publications or documents are linked to this record.
Ran from Mar 2024 to primary completion in Feb 2026, 23 months.
Of 212 non-industry interventional studies with no phase under Hypotension, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 22. This study's 23 months is above that.
Counting every sponsor, half of 219 studies reached it within 12 months; a quarter within 6 and three quarters within 22.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Propranolol · Diltiazem